| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.08 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.08 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.099 | 0.08 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |